Latest in Millennial Retail Investors
Sort by
271 items
-
Investors betting on Treasurys like it’s the 2016 election all over again could be making a big mistake
The market backdrop for this presidential election isn’t remotely like 2016, says Jamie Patton, co-head of global rates at TCWBusiness - MarketWatch - October 31 -
Here’s how ETF investors can lock in higher yields as Treasury rates jumped in October
Defined-maturity bond ladder ETFs could help investors lock in high yields and maturity dates to match their investment goals during periods of heightened market volatility.Business - MarketWatch - October 31 -
Trump-Harris election may take weeks to decide. Here’s what investors must know.
Election Day is supposed to be a one-day affair, but if polls and recent history are a guide, the results of the Nov. 5 presidential race and key congressional contests may not be known for days or ...Business - MarketWatch - November 2 -
Here are the stakes for stocks, bonds, gold and other markets as investors await too-close-to-call election
Investors are bracing for a range of scenarios after voters finish going to the polls on Tuesday.Business - MarketWatch - November 2 -
Here is the most important thing investors can do ahead of the presidential election outcome
The real question is not who will win Tuesday's election — but rather, how quickly will we know who won.Business - CNBC - November 5 -
What top financial advisors are telling investors about the market impact of the U.S. presidential election
Many investors worry the election may shake up their investments. Top financial advisors say it's best to take a long-term view on Election Day and beyond.Business - CNBC - November 5 -
40% of investors are considering this money move after the election: It may cost them 'really great gains,' says market strategist
Making decisions about your portfolio based on the election will likely cost you, experts say. Here's how to keep anxiety from hurting your finances.Business - CNBC - November 5 -
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.Business - MarketWatch - November 5 -
The 3 biggest passive-investing myths Goldman Sachs says investors need to get over
Over the years, passive investing has been accused of being “worse than Marxism,” and of leaving markets “fundamentally broken.”Business - MarketWatch - November 5 -
ADM calls off investor webcast after new confusion over its accounts’ reliability
Company’s share price fell almost 12% in early trade as it vowed to work ‘diligently’ to finalise financial statementsBusiness - Financial Times - November 5